HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Peter A Campochiaro Selected Research

ranibizumab (Lucentis)

7/2015Scatter Photocoagulation Does Not Reduce Macular Edema or Treatment Burden in Patients with Retinal Vein Occlusion: The RELATE Trial.
7/2015Predictors of Functional and Anatomic Outcomes in Patients with Diabetic Macular Edema Treated with Ranibizumab.
12/2014Monthly versus as-needed ranibizumab injections in patients with retinal vein occlusion: the SHORE study.
11/2014Pharmacokinetics of ranibizumab after intravitreal administration in patients with retinal vein occlusion or diabetic macular edema.
9/2014Neutralization of vascular endothelial growth factor slows progression of retinal nonperfusion in patients with diabetic macular edema.
8/2014Interleukin-18 has antipermeablity and antiangiogenic activities in the eye: reciprocal suppression with VEGF.
1/2014Long-term outcomes in patients with retinal vein occlusion treated with ranibizumab: the RETAIN study.
10/2013Long-term outcomes in ranibizumab-treated patients with retinal vein occlusion; the role of progression of retinal nonperfusion.
5/2013Predictive value in retinal vein occlusions of early versus late or incomplete ranibizumab response defined by optical coherence tomography.
2/2013Ranibizumab for edema of the macula in diabetes study: 3-year outcomes and the need for prolonged frequent treatment.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Peter A Campochiaro Research Topics

Disease

42Choroidal Neovascularization
01/2015 - 04/2002
40Macular Edema
11/2015 - 01/2003
25Rupture
07/2014 - 04/2002
22Retinal Neovascularization
08/2014 - 03/2002
20Ischemia
11/2015 - 03/2002
20Retinal Vein Occlusion
08/2015 - 08/2007
20Macular Degeneration (Age-Related Maculopathy)
01/2015 - 01/2006
15Diabetic Retinopathy (Retinopathy, Diabetic)
11/2015 - 06/2002
13Edema
08/2015 - 11/2009
11Retinitis Pigmentosa (Pigmentary Retinopathy)
09/2012 - 07/2006
11Retinal Degeneration
09/2012 - 06/2002
10Anoxia (Hypoxia)
11/2015 - 11/2003
9Retinal Detachment (Retinal Detachments)
10/2014 - 02/2002
9Neoplasms (Cancer)
11/2010 - 05/2003
7Vascular Diseases (Vascular Disease)
11/2015 - 03/2007
4Vitelliform Macular Dystrophy
01/2009 - 02/2003
4Retinal Diseases
10/2008 - 09/2003
4Hyperoxia
11/2007 - 01/2004
3Ganglion Cysts (Ganglion)
07/2010 - 10/2008
3Pathologic Neovascularization
05/2009 - 08/2002
3Epiretinal Membrane (Epiretinal Membranes)
06/2007 - 08/2003
2Cicatrix (Scar)
01/2015 - 05/2006
2Inflammation
12/2012 - 11/2009
2Leukostasis
08/2011 - 01/2007
2Choroid Diseases
06/2010 - 06/2002
2Wounds and Injuries (Trauma)
06/2004 - 03/2003
2Proliferative Vitreoretinopathy
02/2003 - 06/2002
1Cardiovascular Diseases (Cardiovascular Disease)
07/2015
1Cysts
07/2015
1Hypercholesterolemia
07/2015
1Stroke (Strokes)
03/2015
1Pneumonia (Pneumonitis)
03/2015
1Fibrosis (Cirrhosis)
01/2015
1Atrophy
01/2015
1Autoimmune Diseases (Autoimmune Disease)
08/2014
1Retinopathy of Prematurity (Retrolental Fibroplasia)
07/2014
1Uveitis
03/2013

Drug/Important Bio-Agent (IBA)

58Retinaldehyde (Retinal)IBA
11/2015 - 02/2002
53Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2015 - 02/2002
22ranibizumab (Lucentis)FDA Link
07/2015 - 12/2006
7Fluorescein (Funduscein)FDA LinkGeneric
01/2015 - 09/2005
7OxygenIBA
10/2011 - 04/2002
7Messenger RNA (mRNA)IBA
10/2008 - 02/2002
6Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
07/2010 - 08/2003
6pigment epithelium-derived factorIBA
11/2007 - 03/2002
5Proteins (Proteins, Gene)IBA
08/2015 - 04/2005
4Fluocinolone Acetonide (Capex)FDA LinkGeneric
03/2013 - 07/2010
4Phosphotransferases (Kinase)IBA
04/2009 - 08/2003
4ParaquatIBA
11/2007 - 01/2006
4Protein Isoforms (Isoforms)IBA
08/2007 - 04/2002
4PKC412IBA
03/2004 - 05/2003
3Angiopoietin-2IBA
11/2015 - 08/2002
3EndostatinsIBA
08/2015 - 05/2003
3salicylhydroxamic acid (SHAM)IBA
07/2015 - 04/2011
3afliberceptIBA
03/2015 - 11/2009
3Proto-Oncogene Proteins c-sis (Platelet Derived Growth Factor B)IBA
03/2013 - 11/2003
3bevacizumabFDA Link
09/2009 - 08/2007
3Doxycycline (Vibramycin)FDA LinkGeneric
09/2009 - 06/2004
3AntioxidantsIBA
06/2009 - 07/2006
2Class 3 Receptor-Like Protein Tyrosine PhosphatasesIBA
11/2015 - 03/2015
2OpsinsIBA
07/2014 - 09/2009
2tetrachloroisophthalonitrile (Bravo)IBA
05/2013 - 04/2012
2combretastatin A-4 (combretastatin A4)IBA
01/2013 - 08/2003
2Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA
09/2012 - 11/2007
2MecamylamineIBA
05/2010 - 04/2008
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
11/2009 - 01/2007
2superoxide dismutase 1IBA
06/2009 - 09/2006
2Chloride Channels (Chloride Channel)IBA
01/2007 - 02/2003
2CGC-11144IBA
11/2006 - 09/2005
2Angiopoietin-1IBA
07/2005 - 11/2003
2platelet-derived growth factor AIBA
08/2003 - 06/2002
2Platelet-Derived Growth FactorIBA
02/2003 - 06/2002
2Ketorolac Tromethamine (Acular)FDA LinkGeneric
02/2003 - 01/2003
1Insulin-Like Growth Factor Binding ProteinsIBA
08/2015
1Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
08/2015
1persephinIBA
08/2015
1Dexamethasone (Maxidex)FDA LinkGeneric
08/2015
1N-acetyltryptophanamide (NATA)IBA
12/2014
1Thrombospondin 1IBA
08/2014
1Interleukin-18 (Interleukin 18)IBA
08/2014
1platelet-derived growth factor BB (becaplermin)FDA Link
07/2014
1DNA (Deoxyribonucleic Acid)IBA
12/2013
1Daunorubicin (Cerubidine)FDA LinkGeneric
12/2013
1Doxorubicin (Adriamycin)FDA LinkGeneric
12/2013
1chemotactic factor inactivatorIBA
07/2013
1ForskolinIBA
02/2013

Therapy/Procedure

27Intraocular Injections
07/2014 - 06/2002
26Lasers (Laser)
07/2015 - 04/2002
14Injections
07/2015 - 05/2003
7Light Coagulation
07/2015 - 11/2003
5Traction
06/2007 - 02/2002
4Intraperitoneal Injections
07/2014 - 07/2002
3Heterologous Transplantation (Xenotransplantation)
06/2010 - 04/2006
3Oral Administration
03/2004 - 09/2002
2Aftercare (After-Treatment)
08/2014 - 06/2004
2Intravenous Infusions
01/2013 - 02/2008
2Intravitreal Injections
12/2012 - 11/2009
2Intravenous Injections
11/2010 - 12/2005
2Drug Therapy (Chemotherapy)
11/2007 - 08/2007
1Laser Therapy (Surgery, Laser)
02/2013